Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Halesway

- PMLiVE

UK moves to accelerate digital health uptake

Aims to make London the global capital of digital health technologies

- PMLiVE

Novartis’ Entresto launched in UK

Drug was first CHF therapy to show an improvement over ACE inhibitors

- PMLiVE

Biomedical Catalyst funding ‘must continue’, says BIA

UKbiotech body warns against re-appearance of funding 'valley of death'

UK Life Sciences Strategy - one year on

AstraZeneca joins Genomics England consortium

Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines

- PMLiVE

UK CROs to offer drug discovery services to Nordic businesses

Will head to Copenhagen in March for market visit

- PMLiVE

Novartis begins sale talks for Horsham, UK site

Enters negotiations with the University of Brighton

Creating a 21st century life sciences ecosystem

The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

- PMLiVE

Industry welcomes UK’s £6bn science strategy

It will provide funding for projects including a big data collaboration and an ageing-focused innovation centre

UK flag

UK to review life sciences environment

Intends to speed up access to medicines and medical technologies

- PMLiVE

Brain tumour vaccine is UK’s first ‘Promising Innovative Medicine’

Northwest Biotherapeutics’ DCVax-L gets UK version of ‘breakthrough’ status for use in cancer

- PMLiVE

NICE knocks back Celgene’s Abraxane in pancreatic cancer

Says cancer drug's cost not justified by its limited benefit

- PMLiVE

England’s Cancer Drugs Fund: Naughty or NICE?

The decision to extend the CDF raises questions on the future of cancer drug access on the NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links